Cancer Screening

Thyroid cancer incidence and mortality patterns among children and adolescents worldwide mirror data for adults, suggesting overdiagnosis and a need to “explicitly recommend” against screening for the disease in asymptomatic children.

A revised U.S. Preventive Services Task Force guideline could lead to increased lung cancer screening rates among women and racial and ethnic minority populations, according to a study published in JAMA Network Open.

U.S. states with larger declines in PSA screening from 2002 to 2016 also had larger increases in incidence of metastatic prostate cancer at diagnosis, according to a presentation at Genitourinary Cancers Symposium.

MRI improved detection of clinically significant prostate cancer without increasing overdiagnosis compared with PSA testing, according to a prospective, population-based, blinded cohort study published in JAMA Oncology.

Colorectal cancer screening rates among underserved populations increased among patients who received at-home fecal immunochemical tests, according to study results.

A baseline breast density assessment in women aged 40 years followed by annual screening for those with dense breasts may be more cost effective than biennial screening starting at age 50 years, according to researchers.

Substantial decreases in cancer screenings and diagnoses occurred during the first peak of the COVID-19 pandemic across one large U.S. health care system, according to a research letter published in JAMA Oncology.

People who ordered a colorectal cancer screening kit through a patient portal were nearly four times more likely to complete it than those who received a kit automatically in the mail, a retrospective observational study showed.

Today is World Cancer Day.

Draft U.S. Preventive Services Task Force guidelines that aimed to increase the number of minorities eligible for lung cancer screening may instead exacerbate racial and ethnic disparities, study results showed.